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Matching between regional coronary
vasodilator capacity and corresponding
circumferential strain in individuals with normal
and increasing body weight
Gabriella M. Vincenti, MD,a Giuseppe Ambrosio, MD, PhD,b
Jean-Noe¨l Hyacinthe, MD,c Alessandra Quercioli, MD,a Yann Seimbille, MD,c
Franc¸ois Mach, MD,a Osman Ratib, MD,c Jean-Paul Valle´e, MD,c
and Thomas H. Schindler, MDa
Background. To define the relationship between regional coronary vasodilator capacity
and myocardial circumferential strain at rest in normal weight, overweight, and obese indi-
viduals with normal global left-ventricular function.
Methods and Results. Myocardial blood flow at rest and during pharmacologic vasodilation
was measured with 13N-ammonia PET/CT in mL/g/minute in normal weight control (CON,
n 5 12), overweight (OW, n 5 10), and obese individuals (OB, n 5 10). In addition, resting
myocardial function was evaluated as circumferential strain (
”
c, %) by MRI. Global myo-
cardial flow reserve (MFR) did not differ significantly between CON and OW (2.98 ± 0.96 vs
2.70 ± 0.66, P 5 .290), whereas it declined significantly in OB (1.98 ± 1.04, P 5 .030). Further,
global
”
c (%) was comparable between CON, OW, and OB (20.24 ± 0.03, 20.23 ± 0.02, and
20.23 ± 0.04) but it was lowest in OB when normalized to the rate-pressure product (N
”
c:
20.31 ± 0.06, 20.32 ± 0.05, and 20.26 ± 0.08). When MFR of the three major coronary ter-
ritories was correlated with corresponding
”
c, a positive association was observed in CON
(r 5 0.36, P 5 .030), in OW (r 5 0.54, P 5 .002), and also in OB when relating N
”
c to coro-
nary vascular resistance during pharmacologic vasodilation (r 5 20.46, P 5 .010).
Conclusions. Higher coronary vasodilator capacity is related to corresponding regional
circumferential strain at rest in non-obese individuals, while this is also observed for reduced
MFR in obesity. (J Nucl Cardiol 2012;19:693–703.)
Key Words: Coronary circulation Æ myocardial blood flow Æ myocardial function Æ
magnetic resonance imaging Æ obesity Æ positron emission tomography
INTRODUCTION
Normal coronary circulatory function has been
widely appreciated to ascertain important antiathero-
sclerotic and antithrombotic effects mainly via flow-
mediated and endothelium-dependent release of nitric
oxide.1 Cardiovascular risk factors such as arterial
hypertension, hypercholesterolemia, smoking, diabetes
mellitus, and obesity may impair a proper functioning of
the coronary circulation function.1 The identification of
an abnormal coronary circulatory function has been
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demonstrated to provide substantial diagnostic and
prognostic information additional to that derived from
angiographic and coronary risk factor assessment.1-6 The
exact pathophysiological mechanisms underlying abnor-
mal coronary circulatory function remain to be further
elucidated, but increases in reactive oxygen species
associated with an inflammation of the arterial wall have
been suggested as a common final pathway of a
variability of cardiovascular risk factors to alter the
coronary vasodilator capacity.7-9 In the normal setting,
coronary flow increases for maintaining an appropriate
metabolic and oxygen supply of the left ventricle adapt
according to its inotropic state at rest or during phys-
iological stress.10-13 This relationship between left-
ventricular function and myocardial flow is also referred
to as myocardial perfusion-contracting matching.14
Toward this direction, myocardial tagging techniques
with MRI have provided new insight into normal and
abnormal patterns of regional cardiac contractility.15,16
Previous investigations16 have provided some first
evidence that a diminished myocardial flow reserve
(MFR) may be paralleled by a reduced regional myo-
cardial function in asymptomatic cardiovascular risk
individuals as determined with contrast-enhanced MRI
perfusion and tagging studies. As we and others have
demonstrated,17-19 increases in body weight are com-
monly paralleled by a progressive dysfunction of
the coronary circulation, while it may also alter regional
LV function in obese individuals.20 The possible
relationship between coronary circulatory function and
corresponding regional contractility in healthy, normal-
weight, and those with increasing body weight, however,
remains to be elucidated.
With this in mind, we aimed to define a possible
relationship between regional coronary vasodilator
capacity and myocardial circumferential strain or wall
motion at rest in normal-weight, overweight, and obese
individuals with normal global left-ventricular function.
METHODS
Study Population and Design
The study population included 32 asymptomatic individ-
uals without traditional cardiovascular risk factors such as
arterial hypertension, hypercholesterolemia, smoking, and
diabetes mellitus (Table 1). Study participants underwent an
initial screening visit that included a physical examination,
electrocardiogram (ECG), blood pressure measurements, and
routine blood chemistry in a fasting state. Excluded were study
candidates with a history of variant angina, a family history of
premature CAD, or clinically manifest cardiovascular or any
other disease. In addition, no study participant was on any
cardiac or vasoactive medication. Physical examination
revealed normal findings in all study participants and they
had normal resting ECGs. All study participants then under-
went 13N-ammonia PET/CT (64-slice Biograph HiRez
TruePoint PET-CT scanner, Siemens, Erlangen, Germany)
measurements of myocardial blood flow (MBF) at rest and
Table 1. Characteristics of study population (n = 32)
CON (n 5 12) OW (n 5 10) OB (n 5 10) P value
Age (years) 49 ± 17 44 ± 13 48 ± 6 .535
Gender, F/M 6/8 4/6 4/6 /
BMI (kg/m2) 22.7 ± 2.82 27.8 ± 1.52 38.4 ± 5.35 .0001
Waist-hip ratio 0.81 ± 0.08 0.87 ± 0.06 0.94 ± 0.04 .0001
Waist (cm) 83.3 ± 8.39 97.6 ± 8.11 117.6 ± 9.94 .0001
Hip (cm) 102.7 ± 4.64 111.8 ± 4.30 124.5 ± 9.07 .0001
Laboratory result
Cholesterol levels (mg/dL) 186.7 ± 41.90 208.2 ± 35.16 194.7 ± 40.06 .366
LDL level (mg/dL) 130.0 ± 17.98 147.3 ± 16.71 128.2 ± 29.49 .094
HDL level (mg/dL) 48.2 ± 12.11 44.6 ± 14.33 43.8 ± 15.22 .720
Triglyceride level (mg/dL) 80.5 ± 33.46 114.8 ± 49.11 117.5 ± 46.02 .056
Glucose level (mg/dL) 96.3 ± 7.95 95.2 ± 8.16 96.5 ± 7.61 .894
Insulin (mUI/L) 3.0 ± 1.77 12.8 ± 9.31 12.8 ± 6.44 .0001
HOMA 0.70 ± 0.51 2.62 ± 1.68 2.96 ± 1.27 .0001
hs-CRP levels (mg/L) 1.77 ± 1.46 2.66 ± 3.31 7.03 ± 5.58 .008
HbAlc (%) 5.26 ± 0.18 5.36 ± 0.31 5.34 ± 0.30 .397
Values are mean ± SD.
P values between groups by ANOVA.
CON, Controls; OW, overweight; OB, obesity; BMI, body mass index; hs-CRP, high sensitive C-reactive protein; HbAlc, hemoglobin
Alc; HDL, high-density lipoprotein; HOMA, homeostasis model assessment; LDL, low-density lipoprotein.
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during pharmacologically induced hyperemia with dipyridam-
ole in a fasting state to evaluate coronary circulatory function.
A prerequisite for the study inclusion was a normal stress-rest
perfusion imaging on 13N-ammonia PET/CT, which widely
excluded the presence of flow-limiting epicardial CAD
lesions.18 Following, study participants were grouped accord-
ing to their body mass index (BMI, kg/m2): control group
20 B BMI\25 (CON; n = 12), overweight group 25 B BMI\
30 (OW; n = 10), obese group BMI C 30 (OB; n = 10).
Blood chemistry included plasma glucose, hemoglobin
A1c, insulin, total cholesterol, HDL and LDL cholesterol,
triglycerides levels, and high-sensitive C-reactive protein. In
addition, Homeostasis Model Assessment (HOMA) was cal-
culated as index of insulin resistance (HOMA = fasting
plasma glucose [mmol/L] 9 fasting plasma insulin [pmol/L]/
162).21 Within 20 days of the cardiac 13N-ammonia PET/CT
study, cardiac magnetic resonance (CMR) tagging was per-
formed using a 1.5T Espree system (Siemens Medical
Solutions, Erlangen, Germany) to evaluate possible alterations
in global and regional myocardial motion patterns.22 The study
was approved by the University Hospitals of Geneva Institu-
tional Review Board (No: 07-183), and each participant signed
the approved informed consent form.
Quantification of MBF with PET/CT
Following the topogram used to define the axial field-
of-view and a low-dose CT scan (120 kV, 30 mA) for
attenuation correction, PET emission data were acquired
during shallow breathing following intravenous injection of
&500-550 MBq of 13N-ammonia. The CT-based attenuation
correction map was used to reconstruct the PET emission data.
MBF quantification was performed first at rest and then during
pharmacologic vasodilation with dipyridamole-induced hyper-
emia applying intravenously standard dose of 140 lg/kg/
minute.23,24 The relative distribution of 13N-ammonia uptake
of the left ventricle was assessed visually on short- and long-
axis myocardial slices and semiquantitatively on the corre-
sponding polar map from the last static 18-minute transaxial
PET image. Time-activity curves from the first 12-dynamic
frames (12 for 10 seconds each), in concert with a two-
compartment tracer kinetic model,25 were used to calculate
global and regional MBF in mL/g/minute of the left ventricle
with the use of the PMOD software package (version 2.8
PMOD Technologies Ltd, Zurich, Switzerland).18 Regional
MBFs of the LAD, LCx, and RCA territory were averaged on a
polar map and the resulting mean MBF was defined as global
MBF of the left ventricle. Heart rate, blood pressure, and a 12-
lead ECG were recorded continuously during each MBF
measurement. From the average of heart rate and blood
pressure during the first 2 minutes of each image acquisition,
the rate-pressure product (RPP) was determined as an index of
cardiac work. To account for interindividual variations in
coronary driving pressure, an index of coronary vascular
resistance (CVR) was determined as the ratio of mean arterial
blood pressure to MBF (mm Hg/mL/minute/g).
Protocol for Tagged MRI
Image acquisition. Study participants underwent
MRI examination using a 1.5T Espree system (Siemens Medical
Solutions, Erlangen, Germany). Individuals were scanned in the
supine position, using a 6-element anterior body array coil
combined with a 6-element posterior spine coil. Following the
acquisition of localizers, 2-chamber, 4-chamber, and short axis
high-resolution steady state free precession (SSFP) cine imaging
(pixel size = 1.3 9 1.3 9 7 mm3, temporal resolution & 25-
40 ms), myocardial tagging was performed in a three short axis
view with complementary spatial modulation of magnetization
technique.26 We used a prospectively ECG-gated, balanced
SSFP.22 The field of view was 340 9 340 mm, matrix 192 with
32% phase resolution, slice thickness 7 mm, TE 1.2, and flip
angle 20. Tag distance was 7 mm and localized shimming to
adjust the static magnetic field within each slice was performed
prior to acquisition. The temporal resolution was 25-40 ms,
depending on the heart rate and breath-hold capacity of the
subjects. The two tag line directions were acquired in a single
breath-hold in end-expirium.
Strain analysis. For tag analysis, we used extrema
temporal chaining.27 Strain analysis describes the change of
shape of material (i.e., myocardium) resulting from deforma-
tion, which are used to present regional myocardial function.26
In this study, maximal circumferential strain (
”
c, %), reflect-
ing intramural circumferential shortening and defined as
”
c = length (time t) - length (time 0)/(time 0),26 was calcu-
lated semi-automatically from the tracked points of the mid-
wall in six cardiac sectors for three slices (3 short axis views).
Length is given in millimeter and time in seconds. The sectors
were defined according to the AHA 17-segment model.28
Further, the sectors were defined by the software starting from
the RV/LV border assigned by the user. For this study, we
focused on the mid-wall systolic circumferential shortening,
using timing information (onset and peak time) and the mid-
wall systolic circumferential strain. When mentioned, ‘‘wall
motion,’’ it refers to max-min of the circumferential shortening
time curve in the considered cardiac sector. The circumferential
strain data were averaged in the three main coronary perfusion
territories according subtended to the LAD, LCx, and RCA.
The global systolic circumferential strain (g
”
c) was defined as
the circumferential strain averaged across all segments.16
Further, obesity is commonly associated with elevations in
arterial blood pressures and, thus, myocardial workload,18
leading to an increase in left ventricular preload, which may
alter global and regional circumferential strain.
”
c, therefore,
was normalized to the RPP at rest (N
”
c =
”
c divided by RPP
rest multiplied by 10000) to compensate for possible interin-
dividual variations in
”
c (%) due to hemodynamic differences.
Statistical Analysis
Data are presented as mean ± SD for quantitative and
absolute frequencies for qualitative variables. The appropriate
Wilcoxon rank test for independent or paired samples was used.
Comparison between the different groups was performed by
one-way analysis of variance, followed by Scheffe’s multiple
Journal of Nuclear Cardiology Vincenti et al 695
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comparison tests. Pearson’s correlation coefficient (r), assuming
a linear regression, was calculated to investigate possible
associations between MBF and CVR, myocardial strain, and
hemodynamic parameters. Statistical significance was assumed
if a null hypothesis could be rejected at P = .05. All statistical
analyses were performed with SPSS for Windows 18.0 (SPSS).
RESULTS
Patient Characteristics
The clinical and metabolic profiles among the three
groups studied are given in Table 1. The increase in
BMI and waist-hip ratio in the three study groups was
accompanied by a significant increase in fasting insulin
plasma levels, HOMA as index for insulin resistance,
triglycerides, and hs-CRP plasma levels. Conversely,
lipid profile, glucose plasma levels, and HbA1c did not
differ significantly between groups.
Hemodynamics and Global MBF
At baseline, heart rate was comparable between
CON and OW, while it was higher in OB (Table 2).
Further, SBP and DBP did not differ significantly
between groups. As heart rate was higher in OB, also the
resting RPP was significantly higher in OB than in CON
and OW. As regards, the resting MBF was higher in OB
but not significantly different among groups. During
dipyridamole stimulation of hyperemic flows, heart rates
increased significantly from rest, but they were compa-
rable among groups (Table 2). In addition, SBP mildly
decreased during dipyridamole stimulation from rest in
CON and OB, while it remained largely unchanged in
OW. There were no significant differences in heart rate
during pharmacologic vasodilation among the study
groups. Conversely, SBP, DBP, and the RPP progres-
sively increased from CON to OW and OB during
dipyridamole stimulation (Table 2).
Compared with CON, global hyperemic MBFs and
MFR tended to be lower in OW but they decreased
significantly in OB (Figure 1; Table 2). When the global
hyperemic MBFs were related to the mean arterial blood
pressure to account for possible interindividual varia-
tions in coronary driving pressure, the global CVR
(mean arterial blood pressure/MBF) widely mirrored the
MBF values during pharmacologic vasodilation for each
Table 2. Global circumferential strain derived from tagging MRI and global myocardial blood flow
(gMBF), coronary vascular resistance (gCVR), and hemodynamic findings during PET/CT exam
Groups
CON OW OB P value
”
c (%) -0.24 ± 0.03 -0.23 ± 0.02 -0.23 ± 0.04 .918
N
”
c (%) -0.31 ± 0.06 -0.32 ± 0.05 -0.26 ± 0.08 .096
gMBF (mL/minute/g)
gMBF at rest 0.78 ± 0.15 0.74 ± 0.18 0.85 ± 0.23 .382
gMBF during hyperemia 2.21 ± 0.47 1.94 ± 0.49 1.50 ± 0.41 .006
gMFR 2.98 ± 0.96 2.70 ± 0.66 1.98 ± 1.04 .052
gCVR (mm Hg/mL/minute/g)
At rest 110.8 ± 19.70 119.2 ± 29.64 113.2 ± 28.71 .745
Pharmacologic vasodilation 36.6 ± 10.11 47.8 ± 14.88 60.6 ± 13.62 .001
Hemodynamics at rest
Heart rate (beats/minute) 63.6 ± 4.21 62.5 ± 8.19 74.3 ± 14.7 .018
SBP (mm Hg) 115 ± 10.87 116.7 ± 10.3 122.3 ± 9.57 .251
DBP (mm Hg) 68.8 ± 9.58 66.9 ± 7.81 75.3 ± 8.22 .089
RPP 7318 ± 921 7247 ± 803 9151 ± 2378 .011
Pharmacologic vasodilation
Heart rate (beats/minute) 83.1 ± 7.25 86.2 ± 5.98 89.8 ± 34.42 .738
SBP (mm Hg) 110.3 ± 9.96 117.4 ± 9.32 121.3 ± 12.28 .059
DBP (mm Hg) 60.3 ± 6.59 64.3 ± 7.41 69.5 ± 10.69 .048
RPP 9125 ± 817 10140 ± 1282 11878 ± 2257 .001
Values are mean ± SD.
P values between groups by ANOVA.
CON, Controls; OW, overweight; OB, obesity;
”
c (%), maximal circumferential strain; N
”
c (%), normalized
”
c (%); MBF, myocardial
blood flow; MFR, myocardial flow reserve; CVR, coronary vascular resistance; SBP, systolic blood pressure.
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group studied (Table 2). The group comparison of
global hyperemic MBF, CVR, and MFR in CON was
significantly different from OW and OB, respectively
(P B .05 by ANOVA).
Regional MBFs and Circumferential Strain
Regional MBFs at rest, during pharmacologically
induced hyperemia and the corresponding MFR in the
territory supplied by the LAD, LCx, and RCA did not
differ significantly within CON, OW, and OB
(Table 3). The intergroup comparison did not reveal
significant differences among groups for regional
resting flow, whereas regional hyperemic MBF and
MFR were significantly lower in OB. In addition,
regional CVR at rest and during dipyridamole stim-
ulation widely mirrored those of regional MBF of
study group (Table 3). As regards, the maximal
circumferential strain (
”
c,%), global
”
c (g
”
c,%), for
all segments was -0.23 ± 0.03 and it did not differ
significantly between groups (Table 2; Figure 2). Also,
the normalized g
”
c (gN
”
c) was comparable between
CON and OW, while significantly lower in OB
(P = .006 and P = .012, respectively) (Table 2).
Addressing regional
”
c and N
”
c within each group
(Table 3), they were significantly greater in the LCx
than in the LAD and lower in the RCA territory
(P \ .05). While regional
”
c for the LAD, LCX, and
RCA territory did not differ between groups, the
corresponding N
”
c values in OB were significantly
lower to those in CON and in OW.
Figure 1. Global hyperemic MBF in CON, OW, and OB.
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Relation Between MBFs, Hemodynamics,
and Circumferential Strain
For the whole study population, global resting MBF
significantly correlated with the corresponding RPP
(r = 0.57, P \ .001, SEE = 0.16). Conversely, there
was no association between global hyperemic MBFs
during pharmacologic vasodilation, MFR, and corre-
sponding RPP, respectively (r = -0.23, P = .188,
SEE = 0.54 and r = 0.25, P = .174, SEE = 0.97).
As regards global
”
c and N
”
c, they correlated inversely
with resting RPP, respectively (r = -0.32, P = .057,
SEE = 0.03 and r = -0.82, P \ .0001, SEE = 967). In
addition, when evaluating the relationship between global
”
c and global MBF at rest, during hyperemia, and MFR,
respectively, no association was observed (r = -0.26,
P = .144, SEE = 0.185; r = 0.30, P = .096, SEE =
0.527; and r = 0.32, P = .071, SEE = 0.947). In con-
trast to this, global N
”
c correlated significantly and
inversely with global resting MBF (r = -0.52, P = .002,
SEE = 0.164), while positively with global hyperemic
MBF and MFR, respectively (r = 0.55, P = .001,
SEE = 0.462 and r = 0.64, P \ .0001, SEE = 0.765).
Regarding regional
”
c, no relationship with regional
MBF or with corresponding CVR at rest in CON, OW,
and OB was observed (Table 4). Conversely, regional
”
c
and corresponding hyperemic MBF, CVR, and MFR
correlated in CON and OW but not in OB (Figure 3).
Further, we evaluated possible associations between
normalized regional
”
c (N
”
c) and coronary flow param-
eters (Table 4). As it was observed, regional N
”
c did not
correlate with corresponding MBF at rest in CON and
OW, while there was a significant and inverse association
in OB. Interestingly, when regional N
”
c was related to
the CVR at rest, it correlated in OW and OB but not in
CON. Further, regional N
”
c was significantly associated
with hyperemic MBF and MFR in CON and OW, but
again not in OB. However, when possible interindividual
differences in intracoronary driving pressure were
Figure 2. Global maximal circumferential strain (
”
c, %) at
rest in CON, OW, and OB.
Table 4. Correlations between regional maximal circumferential strain and flow parameters
CON OW OB
”
c (%) N
”
c (%)
”
c (%) N
”
c (%)
”
c (%) N
”
c (%)
MBF rest r = 0.07 r = 0.16 r = 0.02 r = -0.29 r = -0.25 r = 20.51
P = .712 P = .340 P = .906 P = .120 P = .178 P = .004
SEE = 0.16 SEE = 0.16 SEE = 0.66 SEE = 0.18 SEE = 0.23 SEE 5 0.21
MBF hyperemia r = 0.42 r = 0.64 r = 0.47 r = 0.37 r = 0.09 r = 0.23
P = .011 P < .0001 P = .006 P = .046 P = .636 P = .220
SEE = 0.49 SEE = 0.40 SEE = 0.47 SEE = 0.51 SEE = 0.43 SEE = 0.41
MFR r = 0.36 r = 0.58 r = 0.54 r = 0.63 r = 0.03 r = 0.30
P = .030 P < .0001 P = .002 P < .0001 P = .880 P = .120
SEE = 0.95 SEE = 0.81 SEE = 0.66 SEE = 0.62 SEE = 1.07 SEE = 0.90
CVR rest r = 0.20 r = 0.02 r = 0.12 r = 0.37 r = 0.14 r = 0.37
P = .237 P = .892 P = .525 P = .046 P = .472 P = .043
SEE = 19.8 SEE = 20.2 SEE = 31.4 SEE = 29.4 SEE = 31.6 SEE 5 29.6
CVR hyperemia r = 20.42 r = 20.70 r = 20.54 r = 20.34 r = -0.16 r = 20.46
P = .011 P < .0001 P = .002 P = .056 P = .409 P = .010
SEE = 11.2 SEE = 8.79 SEE = 13.3 SEE = 14.8 SEE = 15.1 SEE 5 12.6
Significant correlations are indicated in bold.
MBF, Myocardial blood flow (mL/g/minute); MFR, myocardial flow reserve; CVR, coronary vascular resistance (mm Hg/mL/g/
minute);
”
c (%), maximal circumferential strain; N
”
c (%), normalized
”
c; SEE, standard error of the estimate.
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accounted by the calculated regional CVR, there was a
significant and inverse relationship between regional
N
”
c and corresponding CVR during dipyridamole stim-
ulation in all the three groups (Figure 4, Table 4).
DISCUSSION
This study is unique in demonstrating a positive
association between increases in regional hyperemic
MBFs or MFR as determined with 13N-ammonia PET
and corresponding regional resting circumferential strain
as assessed with tagging MRI in healthy non-obese
individuals. Regional increases of coronary vasodilator
function, therefore, were paralleled by an enhanced local
circumferential strain at rest. This relationship was also
observed for obese individuals with reduced hyperemic
MBFs but only when values of circumferential strain
were normalized to the RPP and related to the CVR
during dipyridamole stimulation. When looking at the
obesity group with a marked impairment of hyperemic
MBFs and MFR, regional coronary vasodilator function
at first sight was not correlated with resting circumfer-
ential strain. The reason for this observation appears to
be related to confounding effects of higher heart rates,
A
B
C
Figure 3. Correlation between regional hyperemic MBF in
the territory subtended to the LAD, LCx, and RCA and
corresponding local
”
c at rest (%, positive values for display)
in CON (A), OW (B), and OB (C).
A
B
C
Figure 4. Correlation between regional CVR during dipyrid-
amole stimulation in the territory subtended to the LAD, LCx,
and RCA and corresponding local N
”
c at rest (%, positive
values for display) in CON (A), OW (B), and OB (C).
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SBPs, and resulting RPP, indicative of the myocardial
workload, not only at rest but also at pharmacologic
stress in OB when compared to CON and OW. In order
to account for this confounding hemodynamic factor,
which may lead to interindividual differences in coro-
nary driving pressure and an increase in left ventricular
preload or extra-vascular resistive forces, regional CVR
and normalized circumferential strain (N
”
c) were also
evaluated. And indeed, when regional resting N
”
c was
related to corresponding CVR during pharmacologic
vasodilation, we observed a significant and inverse
association. Thus, the higher regional resting N
”
c was
associated with a relatively lower regional CVR during
pharmacologic vasodilation in OB. To our best knowl-
edge, these findings are first to suggest a conditioning of
the coronary vasodilator capacity by resting regional
circumferential strain in healthy individuals with
increasing body weight, which deserves further
investigations.
Resting MBFs, RPP, and Circumferential
Strain
As observed in the current and previous investiga-
tions,10,12 there is a close linear association between
resting MBF and the RPP as an index of cardiac work
and thus myocardial oxygen demand. Increases in
myocardial work, therefore, are closely paralleled by
commensurate MBF increases to appropriately meet
increases in oxygen demand. Interestingly, we could
also demonstrate an inverse association between global
”
c and resting RPP. Increases in resting RPP, therefore,
were associated with relatively lower global circumfer-
ential strain, which can be related to the dependency of
regional myocardial function on left ventricular preload
and afterload, and thus on hemodynamic conditions.16
Such observation could also explain why global
”
c did
not correlate with corresponding resting MBF, whereas a
significant and inverse association was observed for
global N
”
c. Taken together, however, these unique
observations denote a close interrelation between the
regulation of resting MBF, myocardial work load, and
circumferential strain.14
In agreement with recent investigation,18 resting
MBFs in OB was higher than in CON and in OW. This
relative increase in resting global MBF in OB can be
related to higher resting heart rates, SBPs, and corre-
sponding RPP and, in turn, myocardial oxygen
consumption.10 The finding of an increase in myocardial
workload in OB paralleled by higher resting MBF also
accords with previously reported activation of the
sympathetic nervous system and renin-angiotensin-
aldosterone system.18,29 Notably, an increase in arterial
blood pressure at rest may have led not only to an
elevation in resting myocardial workload and, thus,
MBF but also to increase in left ventricular preload and
extra-vascular resistive forces, which, in turn, may have
affected the global circumferential strain. And indeed,
when we compensated for differences in hemodynamic
effects due to increases in resting RPP by calculating the
N
”
c, the global and regional N
”
c was lower in OB,
while comparable between CON and OW. Of further
interest, when we related regional resting N
”
c to
corresponding regional CVR, we observed a positive
and significant association in OW and in OB but not in
CON. This observation may stress that in individuals
with increasing body weight and an increase in left
ventricular preload and extra-vascular resistive forces,
left ventricular myocardium underlies an adaptive and
relative increase regional N
”
c aiming to maintain the
left ventricular ejection volume, which is also known to
reflect the Frank-Starling mechanism.30,31 This, in fact,
could signify a conditioning of the resting coronary flow
by an adaptive increase in regional circumferential wall
motion in individuals with increasing body weight.
Conversely, in the more recently reported multi-ethnic
study of atherosclerosis (MESA) trial, conducted in 74
asymptomatic cardiovascular risk individuals,16 and also
in the 12 CON of this study, resting regional MBF and
corresponding circumferential strain did not closely
accompany each other. Thus, it appears that with
increases in left ventricular pre-load due to relative
elevations in arterial blood pressures, as observed in
individuals with increasing body weight, an adaptive
increase in regional circumferential wall motion ensues
associated with a commensurate change in resting MBF.
Coronary Vasodilator Capacity and
Circumferential Strain
As regards, global hyperemic MBFs and MFR were
observed to be non-significantly lower in OW when
compared to CON, while declining significantly in OB.
This accords with previous reports,17,18,29 emphasizing
some adverse effects of increasing body weight on the
coronary vasodilator capacity. In the aforementioned
MESA trial,16 myocardial flow and myocardial circum-
ferential strain were assessed with cardiac MRI and
evaluated in asymptomatic individuals but with various
traditional cardiovascular risk factors such as arterial
hypertension, hypercholesterolemia, smoking, and dia-
betes mellitus. It was observed that the coronary
vasodilator capacity correlated inversely with myocar-
dial circumferential strain.16 Accordingly, in the MESA
trial diminished hyperemic flows were paralleled by
reduced resting circumferential strain in cardiovascular
risk individuals.16 Therefore, not only the regional
coronary vasodilator capacity but also the corresponding
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circumferential strain was altered by classical cardio-
vascular risk factors in asymptomatic and relatively old
individuals with a mean age of 65 years. The underlying
mechanisms remain uncertain but one possibility is that
classical cardiovascular risk factors have led, at least in
part, to increases of reactive oxygen species and micro-
inflammation in the arterial wall with reductions in the
bioavailability of endothelium-derived nitric oxide as a
common final pathway underlying coronary vasodilator
dysfunction and, possibly, also leading to regional
myocardial dysfunction.32,33 With this study, however,
we extend the observation of an association between
regional coronary vasodilator capacity and correspond-
ing resting myocardial circumferential strain to healthy
individuals with increasing body weight but without
traditional cardiovascular risk factors. This may argue in
favor of yet unknown physiological mechanisms or
interactions between regional coronary vasodilator
capacity and resting circumferential strain. Under phys-
iologic circumstances, cardiac function determines
myocardial oxygen consumption and consequently cor-
onary perfusion.6,14 On the other hand, there is also
experimental evidence that an increase in coronary
perfusion is related to an elevation in oxygen consump-
tion and contractile function, the so called Gregg
phenomenon.34 This phenomenon is likely secondary
to enhanced diastolic distension due to filling of the
coronary microcirculation, also named ‘‘garden house
effect,’’ which may support our observations. Someone
could also argue that, within the complexity of myocar-
dial perfusion-contraction matching,14,35 an increase in
regional circumferential strain at rest is also a reflection
of increase in the demand for hyperemic MBFs or MFR,
respectively, to maintain an appropriate metabolic and
oxygen supply. The described relationship between
regional coronary vasodilator capacity and correspond-
ing resting circumferential strain, however, may also put
forth a conditioning of the coronary vasodilator capacity
by resting regional myocardial circumferential strain.
While such a novel concept may be intuitively correct, it
awaits further confirmation by well-elaborated experi-
mental and clinical investigations.
LIMITATIONS
There are some limitations worthy of consideration
in interpreting these data. First, diffuse CAD and/or focal
structural alterations of the arterial wall could have mildly
affected hyperemic MBFs.24,36 As normal stress and rest
myocardial perfusion images with 13N-ammonia and
PET/CT was an inclusion criterion for study participants,
effects of flow-limiting epicardial lesions can be widely
ruled out.1 In addition, because study participants were
asymptomatic, the performance of non-invasive MDCT
coronary angiography37 to visualize coronary morphol-
ogy and structure did not seem to be justified. For this
reason, some subclinical structural CAD with mild down-
stream effects on coronary flows may have been missed in
this study population.24,36,38 Second, it may be seen as a
limitation that, apart from the left ventricular circumfer-
ential strain at rest, we did not measure peak longitudinal
strain with tagging MRI due to time constraints, which
might have been more sensitive in the identification of
subtle abnormalities of regional LV contractile func-
tion.20,39 Although, measures of circumferential strain
with cardiac MRI are of high precision due to numerous
tags around the perimeter of the heart,26 which yields a
high sensitivity in the identification of subtle regional
myocardial motion abnormalities,40 information on the
reproducibility of strain measurements is still lacking.
Also, the assessment of regional circumferential strain
with cardiac MRI during dobutamine stimulation would
have been a better approach to depict a possible perfu-
sion-contraction mismatch in OB individuals during
times demand-induced flow supply,41,42 which should
be evaluated in future studies. Finally, in view of the
relatively low number of study participants, current
findings may rather be seen as exploratory, while they are
likely to stimulate further clinical investigations in this
developing research field.
CONCLUSIONS
Higher coronary vasodilator capacity is related to
corresponding regional circumferential strain at rest in
non-obese individuals, while this is also observed for
reduced hyperemic flows and MFR in obesity.
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